Cough syrup issue: Health ministry directs rational use of medication

Union health secretary convened a meeting with states to address drug quality after multiple child deaths linked to contaminated cough syrups like Coldrif, found with DEG/EG. States were directed on rational use, while DGHS advised against prescribing such medicines for children under two, emphasizing careful evaluation for older kids. Probes are underway, and some states have banned the syrups.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fpu3oe4
via IFTTT

Read More

NSE to build Rs 380-crore facility for cancer treatment at Tata Memorial Centre

NSE will build a 380 crore rupee cancer treatment facility at Tata Memorial Hospital. This 11-storey block and bone marrow transplant centre will be in Navi Mumbai. It will serve 1.3 lakh outpatients and conduct over 600 BMTs annually. The facility will have 60 beds. Operations are expected to begin by July 2027.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/E3MQqC6
via IFTTT

Read More

India's TB fight gets a boost: New Made-in-India diagnostic tests cut cost & time

India's ICMR has validated two new indigenous TB diagnostic tools from Huwel Lifesciences. The Quantiplus MTB FAST kit offers cheaper, open-system RT-PCR testing on existing machines, while UniAMP MTB uses non-invasive tongue swabs for patient-friendly diagnosis. These innovations promise faster, more accessible, and affordable TB detection, boosting India's elimination efforts.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HYprjS0
via IFTTT

Read More

Torrent Pharma gets demand notices totalling Rs 6.63 cr from NPPA

Torrent Pharmaceuticals reported receiving demand notices from the NPPA. The notices total over Rs 6.63 crore. They allege overcharging for five drugs between January 2016 and November 2018. The company stated these notices were received on October 3, 2025. Torrent Pharmaceuticals expects no material financial impact from this development.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yrTJDqE
via IFTTT

Read More

Health Ministry confirms Diethylene Glycol beyond permissible limits in Coldrif cough syrup amid child deaths in Raj, MP

The Ministry of Health confirmed Coldrif Cough Syrup from Sresan Pharma's Kanchipuram unit contained diethylene glycol (DEG) above permissible limits, following investigations into child deaths in Madhya Pradesh and Rajasthan. Tamil Nadu banned its sale, halting production. Authorities initiated risk-based inspections and advised against prescribing cough syrup to children under two.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Q1aO7u2
via IFTTT

Read More

Tamil Nadu bans ''Coldrif'' cough syrup after child deaths in MP, Rajasthan

Tamil Nadu has banned the sale of 'Coldrif' cough syrup, manufactured by a city-based firm, following suspicions linking it to 11 child deaths in Madhya Pradesh and Rajasthan. Inspections were conducted, and samples are being tested for Diethylene Glycol. The Union Health Ministry also advised against prescribing cough and cold medications for children under two years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/y2LmXx6
via IFTTT

Read More

Isabgol processors threaten to halt purchases from October 6 over GST

Isabgol processors threaten to halt purchases from farmers due to GST ambiguities, locking up capital for over a year. The industry, exporting ₹3,500 crore annually, faces financial stress and slowed exports as unclear classifications force them to pay GST on seeds, despite refunds. They demand government clarification.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/szVjFdB
via IFTTT

Read More